Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Water Street Healthcare Partners Acquires Pharmaceutical Development BusinessFrom AAIPharma Inc.

By Pharmaceutical Processing | July 17, 2009

Water Street Healthcare Partners, aleading private equity firm focused exclusively on the health care industry,announced today that it has acquired the Pharmaceutical Development divisionfrom AAIPharma Inc. Water Street has committed up to $75 million in equityfinancing to expand the business’ capabilities with the goal of building itinto the leading provider of pharmaceutical development services. The newcompany is named AAIPharma Services Corp. The company, which will retain its headquarters in Wilmington, NorthCarolina, serves more than 300 large pharmaceutical and biotechnologycompanies throughout North America. Its team of 450 scientists andprofessionals specialize in services that encompass the entire process ofpharmaceutical drug development from discovery through commercialization. Itsprimary areas of expertise include analytical chemistry, formulationdevelopment, clinical packaging, oral drug delivery and contractmanufacturing. “We are thrilled to partner with Water Street to establish ourselves as anindependent company,” said L. Lee Karras, who has led the business for thepast 3 years and has been appointed the company’s CEO. “In addition toproviding significant capital resources, Water Street offers extensivepharmaceutical expertise that will benefit our company, employees andcustomers as we embark on a new strategic course. Together with Water Street,we will build on our core strengths to provide our customers with unparalleledknowledge and capabilities that will enable them to successfully navigate thecomplex drug development process.” “The rising complexity of drug development and the costs related tomaintaining those capabilities in-house are leading global pharmaceutical andbiotech companies to increasingly turn to outside resources for assistance,”said Al Heller, an operating partner with Water Street who has more than 30years of pharmaceutical experience including leading operations for G.D.Searle. “AAIPharma Services goes beyond traditional levels of support toprovide customers with unique expertise and capabilities that creativelyaddress challenges that arise during drug development and manufacturing. Thecompany is highly regarded for collaborating with customers to ensure theyconsistently achieve high-quality results. This is the unique valueproposition that we intend to build on.” AAIPharma Services is Water Street’s second platform investment in 2009and first investment in the life sciences sector. Tim Dugan, managingpartner of Water Street, commented: “We are pleased that Water Streetcontinues to complete investments in sectors of health care that we haveidentified as attractive for growth. Over the past 30 years, the AAIPharmaceutical Development business has consistently grown to achieve strongresults. As a stand-alone entity, AAIPharma Services is much betterpositioned to focus on and expand its core business. We will leverage ourteam’s deep expertise and relationships in the pharmaceutical industry tobuild on its strong foundation through a combination of organic growth andstrategic acquisitions. Ultimately, our goal is to create greater long-termvalue for customers and the company by establishing AAIPharma Services as theleading provider of drug development services.”

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE